Loading
Latest filing published 04 Jun 2026 for Oncolytics Biotech Inc., €171k. Read the official filing
No signal scores available.
Andrew P. Aromando has a single filing on record, published on 4 June 2026: an option exercise of €171k in Oncolytics Biotech Inc. One trade is not enough to describe a pattern. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration